PI3K–mTOR Pathway Inhibition Exhibits Efficacy Against High-grade Glioma in Clinically Relevant Mouse ModelsFan Lin, Olaf van Tellingen, Rolf W. Sparidans et al.|Clinical Cancer Research|2016Cited by 82
Targeting core (mutated) pathways of high-grade gliomas: challenges of intrinsic resistance and drug effluxFan Lin, Olaf van Tellingen, Mark C. de Gooijer et al.|CNS Oncology|2013Cited by 22
Supplementary methods from PI3K–mTOR Pathway Inhibition Exhibits Efficacy Against High-grade Glioma in Clinically Relevant Mouse ModelsFan Lin, Olaf van Tellingen, Mark C. de Gooijer et al.|Unknown|2023Cited by 0
Supplementary Figure 1 from PI3K–mTOR Pathway Inhibition Exhibits Efficacy Against High-grade Glioma in Clinically Relevant Mouse ModelsFan Lin, Olaf van Tellingen, Mark C. de Gooijer et al.|Unknown|2023Cited by 0
Data from PI3K–mTOR Pathway Inhibition Exhibits Efficacy Against High-grade Glioma in Clinically Relevant Mouse ModelsFan Lin, Olaf van Tellingen, Mark C. de Gooijer et al.|Unknown|2023Cited by 0